Company Filing History:
4 out of 455 
1 out of 236 
1 out of 194 Years Active: 1993-1999
Title: The Innovations of Robert J Dinerstein
Introduction
Robert J Dinerstein is a notable inventor based in Cincinnati, OH. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various medical conditions. With a total of six patents to his name, Dinerstein's work has had a considerable impact on the treatment of neoplastic diseases and other disorders.
Latest Patents
Dinerstein's latest patents include "Alkyloxyamino substituted fluorenones and their use as protein kinase-C." This invention describes certain alkyloxyamino-substituted fluorenones that inhibit protein kinase C. The compounds are useful for treating neoplastic disease states, disorders associated with abnormal blood flow, and inflammatory diseases. Another significant patent is for "Calcium uptake inhibitors," which relates to 1-aryl-3-pyridinyl-2-propene-1-ones. These compounds serve as calcium uptake inhibitors in leukocytes and thrombocytes, with pharmaceutical compositions containing these active ingredients.
Career Highlights
Throughout his career, Dinerstein has worked with prominent companies such as Merrell Dow Pharmaceuticals and Hoechst Marion Roussel. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and patent development.
Collaborations
Dinerstein has collaborated with notable coworkers, including Keith A Diekema and Jeffrey S Sabol. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.
Conclusion
Robert J Dinerstein's contributions to pharmaceutical innovations through his patents demonstrate his commitment to advancing medical treatments. His work continues to influence the industry and improve patient outcomes.